Viz.ai Unveils AI-Powered Software for 3D CTA Neurovascular Imaging
Offering automated conversion of computed tomography angiography (CTA) into 3D images, Viz 3D CTA reportedly facilitates real-time insights into complex neurovascular anatomy.
While traditional neurovascular imaging poses challenges with manual 3D renderings, limited spatial context and difficulty in visualizing more distal vessel abnormalities, the launch of the artificial intelligence (AI) software Viz 3D CTA may provide a viable alternative.
Providing automated conversion of computed tomography angiography (CTA) scans into high-resolution 3D views in minutes, the Viz 3D CTA software enhances diagnostic clarity and efficiency, according to Viz.ai, the developer of the software.
The newly launched Viz 3D CTA software provides automated conversion of computed tomography angiography (CTA) scans into real-time, high-resolution 3D views of neurovascular anatomy, according to Viz.ai, the developer of the software. (Image courtesy of Viz.ai .)
The company said key attributes of Viz 3D CTA include skull-stripped views, automated post-processing and interactive tools including sagittal and axial rotation.
“Viz 3D CTA gives me a clearer, faster view of what’s going on. Being able to rotate the image and see vessels from different angles makes a big difference, especially in tricky areas,” said Benjamin Alwood, M.D., an assistant professor of vascular neurology at the University of Florida. “It’s also a great safety net for spotting occlusions that might otherwise be missed. Having this kind of clarity right away helps me make quicker, more confident decisions.”
CT Perfusion Study Shows Enhanced Detection of Medium Vessel Occlusions with Emerging AI Software
May 21st 2025The Rapid CTP AI software offered 23 percent greater detection of medium vessel occlusions in comparison to the Viz CTP AI software, according to research presented at the European Stroke (Organization) Conference (ESOC).
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
